1. Home
  2. ACCL vs HOWL Comparison

ACCL vs HOWL Comparison

Compare ACCL & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ACCL

Acco Group Holdings Limited Ordinary Shares

HOLD

Current Price

$1.66

Market Cap

20.2M

ML Signal

HOLD

Logo Werewolf Therapeutics Inc.

HOWL

Werewolf Therapeutics Inc.

HOLD

Current Price

$0.36

Market Cap

18.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACCL
HOWL
Founded
2009
2017
Country
Hong Kong
United States
Employees
22
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.2M
18.9M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
ACCL
HOWL
Price
$1.66
$0.36
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$5.00
AVG Volume (30 Days)
714.2K
627.7K
Earning Date
05-20-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.40
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$17.13
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.23
$0.34
52 Week High
$5.00
$2.23

Technical Indicators

Market Signals
Indicator
ACCL
HOWL
Relative Strength Index (RSI) 59.89 30.97
Support Level $1.31 N/A
Resistance Level $2.16 $0.74
Average True Range (ATR) 0.26 0.04
MACD 0.02 0.01
Stochastic Oscillator 44.19 8.46

Price Performance

Historical Comparison
ACCL
HOWL

About ACCL Acco Group Holdings Limited Ordinary Shares

Acco Group Holdings Ltd is a holding company. Through its Operating Subsidiaries, it is a multi-disciplinary, IT-driven corporate service provider with a presence in Hong Kong and Singapore. Under the Accolade brand, it specializes in offering corporate secretarial services and accounting services in Hong Kong, as well as intellectual properties (IP) registration services in Singapore. Leveraging developed IT solutions, It provides comprehensive, reliable and professional support to its clients, enabling them to focus on their core business activities while it manages and handles their corporate compliance needs. Its clientele ranges from individual clients, small and medium-sized enterprises to multinational corporations, reflecting its ability to cater to diverse business needs.

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging the proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. It has one reportable segment, which focuses on the discovery and development of cancer therapeutics.

Share on Social Networks: